SLC6A3 and Parkinson disease: The lack of differences in AIs of striatal DAT binding between the “Body-First” and “Brain-First” subtypes, when using constipation as a proxy for the “Body-First” phenotype, is consistent with another study that found no association between gastrointestinal disturbances and a more symmetrical dopaminergic binding in PD patients12.